Health
No benefit from virus blood plasma: study – The West Australian
A trial looking at whether blood plasma from COVID-19 patients can help those who are seriously ill does not appear to work in ICU patients, researchers say.
An international trial testing convalescent blood plasma on COVID-19 patients with moderate and severe illness has halted enrolment of severely ill COVID-19 patients requiring intensive care after it found no benefit, trial investigators say.
The decision by the REMAP-CAP trial leaders came after an initial analysis of more than 900 severely ill trial participants in intensive care showed that treatment with the product – an antibody-rich plasma taken from people who have recovered from the pandemic…
-
General10 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
General23 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
General24 hours agoLiberal poll blow days after MP’s retreat to backbench
-
Noosa News17 hours agoYork family honours late son with tractor museum to fund cancer research